Rare diseases
Investigational molecules
Locations
Back to France458 clinical trials in Amiens, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
FranceStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
FranceFranceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
FranceStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
FranceA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FranceEfficacy and safety of osilodrostat with drug combination in patients with hypertension caused by Cushing's syndrome
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancers and multiple myeloma treatments. Studies include novel combination therapies and targeted approaches for improved patient outcomes.
Research emphasizes personalized treatment approaches combining immunotherapy with conventional treatments.
Comprehensive research into heart failure prevention and chronic kidney disease management, with focus on innovative therapeutic combinations.
Trials exploring new drug combinations and surgical interventions for improved cardiovascular outcomes.
Studies investigating treatments for Crohn's Disease and other inflammatory conditions, including innovative microbiota-based approaches.
Focus on developing targeted therapies and investigating treatment discontinuation strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
